Trinity Biotech | TRIB - Passivo Circulante





Passivo Circulante Alterar Data
Abbott USD 16.15B 1.66B 2026-09
Bayer EUR 29.4B 2.87B 2026-09
Bio-Rad Laboratories USD 969.1M 7.8M 2026-09
EDAP TMS EUR 37.51M 6.1M 2026-03
J&J USD 55.46B 562M 2026-09
Mesa Laboratories USD 54.4M 6.1M 2025-12
OraSure Technologies USD 25.12M 18.96M 2026-06
Plus Therapeutics USD 8.57M 612K 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Siemens EUR 45.11B 4.4B 2026-06
Thermo Fisher Scientific USD 14.17B 899M 2026-09
Tosoh JPY 404.7B 12.78B 2026-09
Trinity Biotech USD 143.68M 2.48M 2026-03
Veracyte USD 84.21M 21.47M 2026-09